Pfizer, Others Tell High Court PTAB Unfair To Patent Owners
Two major drug industry groups and a range of large companies including Pfizer and Qualcomm have urged the U.S. Supreme Court to rule that the same Patent Trial and Appeal Board...To view the full article, register now.
Already a subscriber? Click here to view full article